losartan + diphenhydramine + placebo

This is a combination of three components: **losartan**, **diphenhydramine**, and **placebo**. - **Losartan** is an angiotensin II receptor blocker (ARB) primarily used to manage high blood pressure (hypertension), reduce the risk of stroke in certain patients, and treat diabetic nephropathy in patients with type 2 diabetes. Its main mechanism is the selective blockade of the angiotensin II type 1 receptor, leading to vasodilation, reduced secretion of vasopressin, and decreased aldosterone output, thereby lowering blood pressure[1][3]. - **Diphenhydramine** is a first-generation antihistamine used for treating allergies, as a sleep aid, and for its antiemetic and antitussive effects. It acts as an inverse agonist at histamine H1 receptors and also blocks muscarinic acetylcholine receptors, resulting in pronounced sedative and anticholinergic effects[7]. - **Placebo** is an inert substance used as a control in clinical trials and has no pharmacological action. This combination does not exist as a marketed or standard pharmaceutical product; it would typically be used in clinical trial scenarios to test drug interactions, efficacy, or side effect profiles. There may be additive sedative and hypotensive effects when losartan and diphenhydramine are co-administered[2][4].